SG Americas Securities LLC Raises Stock Position in Baxter International Inc. $BAX

SG Americas Securities LLC increased its stake in shares of Baxter International Inc. (NYSE:BAX) by 2,319.6% during the 3rd quarter, Holdings Channel.com reports. The fund owned 298,704 shares of the medical instruments supplier’s stock after purchasing an additional 286,359 shares during the quarter. SG Americas Securities LLC’s holdings in Baxter International were worth $6,801,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of BAX. CoreFirst Bank & Trust acquired a new stake in shares of Baxter International in the 2nd quarter valued at about $27,000. Creative Financial Designs Inc. ADV boosted its holdings in shares of Baxter International by 169.6% in the second quarter. Creative Financial Designs Inc. ADV now owns 984 shares of the medical instruments supplier’s stock valued at $30,000 after acquiring an additional 619 shares during the period. MTM Investment Management LLC purchased a new position in shares of Baxter International during the second quarter worth approximately $30,000. CYBER HORNET ETFs LLC acquired a new position in shares of Baxter International in the 2nd quarter valued at $40,000. Finally, MUFG Securities EMEA plc acquired a new position in shares of Baxter International in the 2nd quarter valued at $46,000. 90.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Cowen reiterated a “hold” rating on shares of Baxter International in a research note on Thursday, October 30th. Argus cut shares of Baxter International from a “buy” rating to a “hold” rating in a report on Friday, October 31st. Evercore ISI decreased their target price on shares of Baxter International from $24.00 to $23.00 in a research note on Monday, January 5th. Jefferies Financial Group dropped their price target on Baxter International from $25.00 to $21.00 and set a “hold” rating on the stock in a research report on Thursday, October 30th. Finally, The Goldman Sachs Group reduced their price objective on Baxter International from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Friday, October 31st. Two research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $21.30.

Baxter International Stock Up 2.0%

Shares of NYSE:BAX opened at $21.10 on Friday. Baxter International Inc. has a fifty-two week low of $17.40 and a fifty-two week high of $37.74. The company has a quick ratio of 1.18, a current ratio of 1.84 and a debt-to-equity ratio of 1.21. The firm’s 50-day simple moving average is $18.83 and its 200-day simple moving average is $22.86. The company has a market cap of $10.84 billion, a price-to-earnings ratio of -31.96, a PEG ratio of 1.21 and a beta of 0.59.

Baxter International (NYSE:BAX) last announced its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.09. Baxter International had a negative net margin of 3.09% and a positive return on equity of 17.38%. The firm had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.88 billion. During the same quarter last year, the firm earned $0.80 earnings per share. The firm’s revenue was up 5.0% compared to the same quarter last year. Baxter International has set its Q4 2025 guidance at 0.520-0.570 EPS and its FY 2025 guidance at 2.350-2.400 EPS. As a group, equities research analysts predict that Baxter International Inc. will post 2.48 earnings per share for the current year.

Baxter International Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 2nd. Investors of record on Friday, November 28th were paid a $0.01 dividend. The ex-dividend date was Friday, November 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Baxter International’s payout ratio is -6.06%.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.